Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Data Bridge Market Research | PRODUCT CODE: 1223410

Cover Image

PUBLISHER: Data Bridge Market Research | PRODUCT CODE: 1223410

NA Throat Cancer Diagnostics Market - Industry Trends and Forecast to 2030

PUBLISHED:
PAGES: 213 Pages
DELIVERY TIME: Inquiry
SELECT AN OPTION
PDF (Single User License) - Printable/Downloadable
USD 3500
PDF (Enterprise License) - Printable/Downloadable
USD 4200

Add to Cart

North America throat cancer diagnostics market is projected to register a substantial CAGR of 7.8% in the forecast period of 2023 to 2030. The new market report contains data for the historic year 2021, the base year of calculation is 2022 and the forecast period is 2023 to 2030.

Market Segmentation:

North America Throat Cancer Diagnostics Market, By Product Type (Instruments and Consumables & Accessories), Test Type (Imaging Test, Blood Test, Biopsy, and Others), Cancer Type (Pharyngeal Cancer and Laryngeal Cancer), Stages (Stage 0, Stage I, Stage II, Stage III and Stage IV), Age Group (30-65, 65 and above, 21-29 and Below 21), End User (Hospitals, Associated Labs, Independent Diagnostic Laboratories, Diagnostic Imaging Centres, Cancer Research Institutes and Others) and By Distribution Channel (Direct Tender and Retail Sales), Country ( U.S., Canada, and Mexico), Industry Trends and Forecast to 2030.

Rising preference for preventive health check-ups

Rising healthcare expenditure

Market Players:

Some of the key market players in North America throat cancer diagnostics market are listed below:

F. Hoffmann-La Roche Ltd.

FUJIFILM Corporation

Thermo Fisher Scientific Inc.

CANON MEDICAL SYSTEMS CORPORATION

Koninklijke Philips N.V.

Merck KGaA

BD

General Electric Company

Illumina

Agilent Technologies, Inc.

Bio-Rad Laboratories, Inc.

Abbott

QIAGEN

Siemens Healthcare GmbH

Myriad Genetics Inc.

Quest Diagnostics Incorporated

Hologic

FONAR Corp.

Time Medical Holding.

MinFound Medical Systems Co., Ltd

PlexBio.

TABLE OF CONTENTS

1 INTRODUCTION 46

  • 1.1 OBJECTIVES OF THE STUDY 46
  • 1.2 MARKET DEFINITION 46
  • 1.3 OVERVIEW OF THE NORTH AMERICA THROAT CANCER DIAGNOSTICS MARKET 46
  • 1.4 LIMITATIONS 48
  • 1.5 MARKETS COVERED 48

2 MARKET SEGMENTATION 51

  • 2.1 MARKETS COVERED 51
  • 2.2 GEOGRAPHICAL SCOPE 52
  • 2.3 YEARS CONSIDERED FOR THE STUDY 53
  • 2.4 CURRENCY AND PRICING 53
  • 2.5 DBMR TRIPOD DATA VALIDATION MODEL 54
  • 2.6 MULTIVARIATE MODELLING 57
  • 2.7 PRODUCT TYPE LIFELINE CURVE 57
  • 2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 58
  • 2.9 DBMR MARKET POSITION GRID 59
  • 2.10 MARKET END USER COVERAGE GRID 60
  • 2.11 VENDOR SHARE ANALYSIS 61
  • 2.12 SECONDARY SOURCES 62
  • 2.13 ASSUMPTIONS 62

3 EXECUTIVE SUMMARY 63

4 PREMIUM INSIGHTS 66

  • 4.1 PESTEL ANALYSIS 67
  • 4.2 PORTER'S FIVE FORCES 68

5 INDUSTRY INSIGHTS 69

6 EPIDEMIOLOGY 70

7 NORTH AMERICA THROAT CANCER DIAGNOSTICS MARKET, REGULATIONS 71

  • 7.1 REGULATORY SCENARIO IN THE U.S 71
  • 7.2 REGULATORY SCENARIO IN AUSTRALIA 72
  • 7.3 REGULATORY SCENARIO IN JAPAN 72
  • 7.4 REGULATORY SCENARIO IN CHINA 72

8 MARKET OVERVIEW 74

  • 8.1 DRIVERS 76
    • 8.1.1 GROWING PREVALENCE OF THROAT CANCER 76
    • 8.1.2 NOVEL TECHNOLOGICAL ADVANCEMENTS IN THROAT CANCER DIAGNOSTICS 76
    • 8.1.3 INCREASE IN AWARENESS REGARDING THROAT CANCER 77
  • 8.2 RESTRAINTS 77
    • 8.2.1 LATE DIAGNOSIS AND POOR PROGNOSIS OF THROAT CANCER 77
    • 8.2.2 HIGH COST FOR THE INSTALLATION OF DIAGNOSTIC DEVICES. 77
  • 8.3 OPPORTUNITIES 78
    • 8.3.1 RISE IN HEALTHCARE EXPENDITURE FOR CANCER DIAGNOSIS AND TREATMENT 78
    • 8.3.2 GOVERNMENT INITIATIVES TOWARD CANCER DIAGNOSTICS 79
    • 8.3.3 STRATEGIC INITIATIVES BY MARKET PLAYERS 79
  • 8.4 CHALLENGES 80
    • 8.4.1 INCREASED COST, SAFETY, AND CONVENIENCE ISSUES 80
    • 8.4.2 LACK OF SKILLED AND CERTIFIED PROFESSIONALS 80

9 NORTH AMERICA THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE 81

  • 9.1 OVERVIEW 82
  • 9.2 INSTRUMENTS 85
    • 9.2.1 PATHOLOGY-BASED INSTRUMENTS 86
      • 9.2.1.1 PCR INSTRUMENTS 86
      • 9.2.1.2 SLIDE STAINING SYSTEMS 86
      • 9.2.1.3 TISSUE PROCESSING SYSTEMS 87
      • 9.2.1.4 CELL PROCESSORS 87
      • 9.2.1.5 OTHER PATHOLOGY-BASED INSTRUMENTS 87
    • 9.2.2 IMAGING INSTRUMENTS 87
      • 9.2.2.1 ULTRASOUND SYSTEMS 87
      • 9.2.2.2 CT SYSTEMS 87
      • 9.2.2.3 MRI SYSTEMS 87
      • 9.2.2.4 OTHERS 88
    • 9.2.3 BIOPSY INSTRUMENTS 88
    • 9.2.4 OTHERS 88
  • 9.3 CONSUMABLES & ACCESSORIES 88
    • 9.3.1 KITS 89
      • 9.3.1.1 PCR KITS 89
      • 9.3.1.2 DNA POLYMERASE KITS 89
      • 9.3.1.3 NUCLEIC ACID ISOLATION KITS 89
      • 9.3.1.4 OTHERS 90
    • 9.3.2 REAGENTS 90
      • 9.3.2.1 ASSAYS 90
      • 9.3.2.2 BUFFERS 90
      • 9.3.2.3 PRIMERS 90
      • 9.3.2.4 OTHERS 90
    • 9.3.3 PROBES 90
    • 9.3.4 OTHER CONSUMABLES 90

10 NORTH AMERICA THROAT CANCER DIAGNOSTICS MARKET, BY TEST TYPE 91

  • 10.1 OVERVIEW 92
  • 10.2 IMAGING TEST 95
    • 10.2.1 COMPUTED TOMOGRAPHY (CT) SCAN 96
    • 10.2.2 MRI 96
    • 10.2.3 CHEST X-RAY 96
    • 10.2.4 POSITRON EMISSION TOMOGRAPHY (PET) SCAN 96
    • 10.2.5 OTHERS 96
  • 10.3 BLOOD TEST 96
    • 10.3.1 BLOOD CHEMISTRY TESTS 98
    • 10.3.2 COMPLETE BLOOD COUNT (CBC) 98
    • 10.3.3 OTHERS 98
  • 10.4 BIOPSY 98
    • 10.4.1 ENDOSCOPIC BIOPSY 99
    • 10.4.2 FINE NEEDLE ASPIRATION (FNA) BIOPSY 99
    • 10.4.3 OTHERS 99
  • 10.5 OTHERS 100

11 NORTH AMERICA THROAT CANCER DIAGNOSTICS MARKET, BY CANCER TYPE 101

  • 11.1 OVERVIEW 102
  • 11.2 PHARYNGEAL CANCER 105
    • 11.2.1 NASOPHARYNGEAL CANCER 106
    • 11.2.2 OROPHARYNGEAL CANCER 106
    • 11.2.3 HYPOPHARYNGEAL CANCER 106
  • 11.3 LARYNGEAL CANCER 107

12 NORTH AMERICA THROAT CANCER DIAGNOSTICS MARKET, BY STAGES 108

  • 12.1 OVERVIEW 109
  • 12.2 STAGE III 112
  • 12.3 STAGE II 112
  • 12.4 STAGE IV 113
  • 12.5 STAGE I 114
  • 12.6 STAGE 0 115

13 NORTH AMERICA THROAT CANCER DIAGNOSTICS MARKET, BY AGE 116

  • 13.1 OVERVIEW 117
  • 13.2 30-65 120
  • 13.3 65 AND ABOVE 121
  • 13.4 21-29 121
  • 13.5 BELOW 21 122

14 NORTH AMERICA THROAT CANCER DIAGNOSTICS MARKET, BY END USER 123

  • 14.1 OVERVIEW 124
  • 14.2 HOSPITALS 127
  • 14.3 ASSOCIATED LABS 127
  • 14.4 INDEPENDENT DIAGNOSTIC LABORATORIES 128
  • 14.5 DIAGNOSTIC IMAGING CENTERS 129
  • 14.6 CANCER RESEARCH INSTITUTES 130
  • 14.7 OTHERS 131

15 NORTH AMERICA THROAT CANCER DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL 132

  • 15.1 OVERVIEW 133
  • 15.2 DIRECT TENDER 136
  • 15.3 RETAIL SALES 137

16 NORTH AMERICA THROAT CANCER DIAGNOSTICS MARKET, BY REGION 138

  • 16.1 NORTH AMERICA 139
    • 16.1.1 U.S. 149
    • 16.1.2 CANADA 154
    • 16.1.3 MEXICO 159

17 NORTH AMERICA THROAT CANCER DIAGNOSTICS MARKET, COMPANY LANDSCAPE 164

  • 17.1 COMPANY SHARE ANALYSIS: NORTH AMERICA 164

18 SWOT ANALYSIS 165

19 COMPANY PROFILE 166

  • 19.1 F. HOFFMANN- LA ROCHE LTD 166
    • 19.1.1 COMPANY SNAPSHOT 166
    • 19.1.2 REVENUE ANALYSIS 166
    • 19.1.3 COMPANY SHARE ANALYSIS 167
    • 19.1.4 PRODUCT PORTFOLIO 167
    • 19.1.5 RECENT DEVELOPMENT 167
  • 19.2 FUJIFILM CORPORATION 168
    • 19.2.1 COMPANY SNAPSHOT 168
    • 19.2.2 REVENUE ANALYSIS 168
    • 19.2.3 COMPANY SHARE ANALYSIS 169
    • 19.2.4 PRODUCT PORTFOLIO 169
    • 19.2.5 RECENT DEVELOPMENT 169
  • 19.3 THERMO FISHER SCIENTIFIC INC. 170
    • 19.3.1 COMPANY SNAPSHOT 170
    • 19.3.2 REVENUE ANALYSIS 170
    • 19.3.3 COMPANY SHARE ANALYSIS 171
    • 19.3.4 PRODUCT PORTFOLIO 171
    • 19.3.5 RECENT DEVELOPMENTS 171
  • 19.4 CANON MEDICAL SYSTEMS CORPORATION 172
    • 19.4.1 COMPANY SNAPSHOT 172
    • 19.4.2 REVENUE ANALYSIS 172
    • 19.4.3 COMPANY SHARE ANALYSIS 173
    • 19.4.4 PRODUCT PORTFOLIO 173
    • 19.4.5 RECENT DEVELOPMENT 173
  • 19.5 KONINKLIJKE PHILIPS N.V. 174
    • 19.5.1 COMPANY SNAPSHOT 174
    • 19.5.2 REVENUE ANALYSIS 174
    • 19.5.3 COMPANY SHARE ANALYSIS 175
    • 19.5.4 PRODUCT PORTFOLIO 175
    • 19.5.5 RECENT DEVELOPMENT 176
  • 19.6 ABBOTT 177
    • 19.6.1 COMPANY SNAPSHOT 177
    • 19.6.2 REVENUE ANALYSIS 177
    • 19.6.3 PRODUCT PORTFOLIO 178
    • 19.6.4 RECENT DEVELOPMENTS 178
  • 19.7 AGILENT TECHNOLOGIES, INC. 179
    • 19.7.1 COMPANY SNAPSHOT 179
    • 19.7.2 REVENUE ANALYSIS 179
    • 19.7.3 PRODUCT PORTFOLIO 180
    • 19.7.4 RECENT DEVELOPMENT 180
  • 19.8 BD 181
    • 19.8.1 COMPANY SNAPSHOT 181
    • 19.8.2 REVENUE ANALYSIS 181
    • 19.8.3 PRODUCT PORTFOLIO 182
    • 19.8.4 RECENT DEVELOPMENTS 182
  • 19.9 BEIJING O&D BIOTECH CO., LTD. 183
    • 19.9.1 COMPANY SNAPSHOT 183
    • 19.9.2 PRODUCT PORTFOLIO 183
    • 19.9.3 RECENT DEVELOPMENT 183
  • 19.10 BIO-RAD LABORATORIES, INC. 184
    • 19.10.1 COMPANY SNAPSHOT 184
    • 19.10.2 REVENUE ANALYSIS 184
    • 19.10.3 PRODUCT PORTFOLIO 185
    • 19.10.4 RECENT DEVELOPMENT 185
  • 19.11 FONAR CORP. 186
    • 19.11.1 COMPANY SNAPSHOT 186
    • 19.11.2 REVENUE ANALYSIS 186
    • 19.11.3 PRODUCT PORTFOLIO 187
    • 19.11.4 RECENT DEVELOPMENT 187
  • 19.12 GE HEALTHCARE 188
    • 19.12.1 COMPANY SNAPSHOT 188
    • 19.12.2 REVENUE ANALYSIS 188
    • 19.12.3 PRODUCT PORTFOLIO 189
    • 19.12.4 RECENT DEVELOPMENT 189
  • 19.13 HOLOGIC INC. 190
    • 19.13.1 COMPANY SNAPSHOT 190
    • 19.13.2 REVENUE ANALYSIS 190
    • 19.13.3 PRODUCT PORTFOLIO 191
    • 19.13.4 RECENT DEVELOPMENT 191
  • 19.14 ILLUMINA, INC. 192
    • 19.14.1 COMPANY SNAPSHOT 192
    • 19.14.2 REVENUE ANALYSIS 192
    • 19.14.3 PRODUCT PORTFOLIO 193
    • 19.14.4 RECENT DEVELOPMENT 193
  • 19.15 MEDONICA CO. LTD 194
    • 19.15.1 COMPANY SNAPSHOT 194
    • 19.15.2 PRODUCT PORTFOLIO 194
    • 19.15.3 RECENT DEVELOPMENT 194
  • 19.16 MERCK KGAA 195
    • 19.16.1 COMPANY SNAPSHOT 195
    • 19.16.2 REVENUE ANALYSIS 195
    • 19.16.3 PRODUCT PORTFOLIO 196
    • 19.16.4 RECENT DEVELOPMENT 196
  • 19.17 MINFOUND MEDICAL SYSTEMS CO., LTD 197
    • 19.17.1 COMPANY SNAPSHOT 197
    • 19.17.2 PRODUCT PORTFOLIO 197
    • 19.17.3 RECENT DEVELOPMENT 197
  • 19.18 MYRIAD GENETICS, INC. 198
    • 19.18.1 COMPANY SNAPSHOT 198
    • 19.18.2 REVENUE ANALYSIS 198
    • 19.18.3 PRODUCT PORTFOLIO 199
    • 19.18.4 RECENT DEVELOPMENT 199
  • 19.19 PLEXBIO 200
    • 19.19.1 COMPANY SNAPSHOT 200
    • 19.19.2 PRODUCT PORTFOLIO 200
    • 19.19.3 RECENT DEVELOPMENT 200
  • 19.20 QIAGEN 201
    • 19.20.1 COMPANY SNAPSHOT 201
    • 19.20.2 REVENUE ANALYSIS 201
    • 19.20.3 PRODUCT PORTFOLIO 202
    • 19.20.4 RECENT DEVELOPMENT 202
  • 19.21 QUEST DIAGNOSTICS INCORPORATED 203
    • 19.21.1 COMPANY SNAPSHOT 203
    • 19.21.2 REVENUE ANALYSIS 203
    • 19.21.3 PRODUCT PORTFOLIO 204
    • 19.21.4 RECENT DEVELOPMENT 204
  • 19.22 SIEMENS HEALTHCARE GMBH 205
    • 19.22.1 COMPANY SNAPSHOT 205
    • 19.22.2 REVENUE ANALYSIS 205
    • 19.22.3 PRODUCT PORTFOLIO 206
    • 19.22.4 RECENT DEVELOPMENT 206
  • 19.23 STERNMED GMBH 207
    • 19.23.1 COMPANY SNAPSHOT 207
    • 19.23.2 PRODUCT PORTFOLIO 207
    • 19.23.3 RECENT DEVELOPMENT 207
  • 19.24 TIME MEDICAL HOLDING. 208
    • 19.24.1 COMPANY SNAPSHOT 208
    • 19.24.2 PRODUCT PORTFOLIO 208
    • 19.24.3 RECENT DEVELOPMENT 208

20 QUESTIONNAIRE 209

LIST OF TABLES

  • TABLE 1 NORTH AMERICA THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 58
  • TABLE 2 NORTH AMERICA INSTRUMENTS IN THROAT CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 59
  • TABLE 3 NORTH AMERICA INSTRUMENTS IN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 60
  • TABLE 4 NORTH AMERICA PATHOLOGY-BASED INSTRUMENTS IN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 60
  • TABLE 5 NORTH AMERICA IMAGING INSTRUMENTS IN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 61
  • TABLE 6 NORTH AMERICA CONSUMABLES & ACCESSORIES IN THROAT CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 62
  • TABLE 7 NORTH AMERICA CONSUMABLES AND ACCESSORIES IN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 63
  • TABLE 8 NORTH AMERICA KITS IN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 63
  • TABLE 9 NORTH AMERICA REAGENTS IN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 64
  • TABLE 10 NORTH AMERICA THROAT CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 68
  • TABLE 11 NORTH AMERICA IMAGING TEST IN THROAT CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 69
  • TABLE 12 NORTH AMERICA IMAGING TEST IN THROAT CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 70
  • TABLE 13 NORTH AMERICA BLOOD TEST IN THROAT CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 71
  • TABLE 14 NORTH AMERICA BLOOD TEST IN THROAT CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 71
  • TABLE 15 NORTH AMERICA BIOPSY IN THROAT CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 72
  • TABLE 16 NORTH AMERICA BIOPSY IN THROAT CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 73
  • TABLE 17 NORTH AMERICA OTHERS IN THROAT CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 74
  • TABLE 18 NORTH AMERICA THROAT CANCER DIAGNOSTICS MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 78
  • TABLE 19 NORTH AMERICA PHARYNGEAL CANCER IN THROAT CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 79
  • TABLE 20 NORTH AMERICA PHARYNGEAL CANCER IN THROAT CANCER DIAGNOSTICS MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 80
  • TABLE 21 NORTH AMERICA LARYNGEAL CANCER IN THROAT CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 81
  • TABLE 22 NORTH AMERICA THROAT CANCER DIAGNOSTICS MARKET, BY STAGES, 2021-2030 (USD MILLION) 85
  • TABLE 23 NORTH AMERICA STAGE III IN THROAT CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 86
  • TABLE 24 NORTH AMERICA STAGE II IN THROAT CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 87
  • TABLE 25 NORTH AMERICA STAGE IV IN THROAT CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 87
  • TABLE 26 NORTH AMERICA STAGE I IN THROAT CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 88
  • TABLE 27 NORTH AMERICA STAGE 0 IN THROAT CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 89
  • TABLE 28 NORTH AMERICA THROAT CANCER DIAGNOSTICS MARKET, BY AGE GROUP, 2021-2030 (USD MILLION) 93
  • TABLE 29 NORTH AMERICA 30-65 IN THROAT CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 94
  • TABLE 30 NORTH AMERICA 65 AND ABOVE IN THROAT CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 95
  • TABLE 31 NORTH AMERICA 21-29 IN THROAT CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 96
  • TABLE 32 NORTH AMERICA BELOW 21 IN THROAT CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 96
  • TABLE 33 NORTH AMERICA THROAT CANCER DIAGNOSTICS MARKET, BY END USER, 2021-2030 (USD MILLION) 100
  • TABLE 34 NORTH AMERICA HOSPITAL IN THROAT CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 101
  • TABLE 35 NORTH AMERICA ASSOCIATED LABS IN THROAT CANCER DIAGNOSTICS MARKET, 2021-2030 (USD MILLION) 102
  • TABLE 36 NORTH AMERICA INDEPENDENT DIAGNOSTIC LABORATORIES IN THROAT CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 102
  • TABLE 37 NORTH AMERICA DIAGNOSTIC IMAGING CENTERS IN THROAT CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 103
  • TABLE 38 NORTH AMERICA CANCER RESEARCH INSTITUTES IN THROAT CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 104
  • TABLE 39 NORTH AMERICA OTHERS IN THROAT CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 105
  • TABLE 40 NORTH AMERICA THROAT CANCER DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION) 109
  • TABLE 41 NORTH AMERICA DIRECT TENDER IN THROAT CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 110
  • TABLE 42 NORTH AMERICA RETAIL SALES IN THROAT CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 111
  • TABLE 43 NORTH AMERICA THROAT CANCER DIAGNOSTICS MARKET, BY COUNTRY, 2021-2030 (USD MILLION) 118
  • TABLE 44 NORTH AMERICA THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 118
  • TABLE 45 NORTH AMERICA INSTRUMENTS IN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 118
  • TABLE 46 NORTH AMERICA PATHOLOGY-BASED INSTRUMENTS IN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 118
  • TABLE 47 NORTH AMERICA IMAGING INSTRUMENTS IN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 119
  • TABLE 48 NORTH AMERICA CONSUMABLES & ACCESSORIES IN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 119
  • TABLE 49 NORTH AMERICA KITS IN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 119
  • TABLE 50 NORTH AMERICA REAGENTS IN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 119
  • TABLE 51 NORTH AMERICA THROAT CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 120
  • TABLE 52 NORTH AMERICA IMAGING TEST IN THROAT CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 120
  • TABLE 53 NORTH AMERICA BLOOD TEST IN THROAT CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 120
  • TABLE 54 NORTH AMERICA BIOPSY IN THROAT CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 120
  • TABLE 55 NORTH AMERICA THROAT CANCER DIAGNOSTICS MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 121
  • TABLE 56 NORTH AMERICA PHARYNGEAL CANCER IN THROAT CANCER DIAGNOSTICS MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 121
  • TABLE 57 NORTH AMERICA THROAT CANCER DIAGNOSTICS MARKET, BY STAGES, 2021-2030 (USD MILLION) 121
  • TABLE 58 NORTH AMERICA THROAT CANCER DIAGNOSTICS MARKET, BY AGE GROUP, 2021-2030 (USD MILLION) 121
  • TABLE 59 NORTH AMERICA THROAT CANCER DIAGNOSTICS MARKET, BY END USER, 2021-2030 (USD MILLION) 122
  • TABLE 60 NORTH AMERICA THROAT CANCER DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION) 122
  • TABLE 61 U.S. THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 123
  • TABLE 62 U.S. INSTRUMENTS IN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 123
  • TABLE 63 U.S. PATHOLOGY-BASED INSTRUMENTS IN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 123
  • TABLE 64 U.S. IMAGING INSTRUMENTS IN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 124
  • TABLE 65 U.S. CONSUMABLES & ACCESSORIES IN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 124
  • TABLE 66 U.S. KITS IN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 124
  • TABLE 67 U.S. REAGENTS IN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 124
  • TABLE 68 U.S. THROAT CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 125
  • TABLE 69 U.S. IMAGING TEST IN THROAT CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 125
  • TABLE 70 U.S. BLOOD TEST IN THROAT CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 125
  • TABLE 71 U.S. BIOPSY IN THROAT CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 125
  • TABLE 72 U.S. THROAT CANCER DIAGNOSTICS MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 126
  • TABLE 73 U.S. PHARYNGEAL CANCER IN THROAT CANCER DIAGNOSTICS MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 126
  • TABLE 74 U.S. THROAT CANCER DIAGNOSTICS MARKET, BY STAGES, 2021-2030 (USD MILLION) 126
  • TABLE 75 U.S. THROAT CANCER DIAGNOSTICS MARKET, BY AGE GROUP, 2021-2030 (USD MILLION) 126
  • TABLE 76 U.S. THROAT CANCER DIAGNOSTICS MARKET, BY END USER, 2021-2030 (USD MILLION) 127
  • TABLE 77 U.S. THROAT CANCER DIAGNOSTICS MARKET, BY END USER, 2021-2030 (USD MILLION) 127
  • TABLE 78 CANADA THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 128
  • TABLE 79 CANADA INSTRUMENTS IN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 128
  • TABLE 80 CANADA PATHOLOGY-BASED INSTRUMENTS IN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 128
  • TABLE 81 CANADA IMAGING INSTRUMENTS IN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 129
  • TABLE 82 CANADA CONSUMABLES & ACCESSORIES IN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 129
  • TABLE 83 CANADA KITS IN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 129
  • TABLE 84 CANADA REAGENTS IN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 129
  • TABLE 85 CANADA THROAT CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 130
  • TABLE 86 CANADA IMAGING TEST IN THROAT CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 130
  • TABLE 87 CANADA BLOOD TEST IN THROAT CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 130
  • TABLE 88 CANADA BIOPSY IN THROAT CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 130
  • TABLE 89 CANADA THROAT CANCER DIAGNOSTICS MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 131
  • TABLE 90 CANADA PHARYNGEAL CANCER IN THROAT CANCER DIAGNOSTICS MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 131
  • TABLE 91 CANADA THROAT CANCER DIAGNOSTICS MARKET, BY STAGES, 2021-2030 (USD MILLION) 131
  • TABLE 92 CANADA THROAT CANCER DIAGNOSTICS MARKET, BY AGE GROUP, 2021-2030 (USD MILLION) 131
  • TABLE 93 CANADA THROAT CANCER DIAGNOSTICS MARKET, BY END USER, 2021-2030 (USD MILLION) 132
  • TABLE 94 CANADA THROAT CANCER DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION) 132
  • TABLE 95 MEXICO THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 133
  • TABLE 96 MEXICO INSTRUMENTS IN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 133
  • TABLE 97 MEXICO PATHOLOGY-BASED INSTRUMENTS IN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 133
  • TABLE 98 MEXICO IMAGING INSTRUMENTS IN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 134
  • TABLE 99 MEXICO CONSUMABLES & ACCESSORIES IN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 134
  • TABLE 100 MEXICO KITS IN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 134
  • TABLE 101 MEXICO REAGENTS IN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 134
  • TABLE 102 MEXICO THROAT CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 135
  • TABLE 103 MEXICO IMAGING TEST IN THROAT CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 135
  • TABLE 104 MEXICO BLOOD TEST IN THROAT CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 135
  • TABLE 105 MEXICO BIOPSY IN THROAT CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 135
  • TABLE 106 MEXICO THROAT CANCER DIAGNOSTICS MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 136
  • TABLE 107 MEXICO PHARYNGEAL CANCER IN THROAT CANCER DIAGNOSTICS MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 136
  • TABLE 108 MEXICO THROAT CANCER DIAGNOSTICS MARKET, BY STAGES, 2021-2030 (USD MILLION) 136
  • TABLE 109 MEXICO THROAT CANCER DIAGNOSTICS MARKET, BY AGE GROUP, 2021-2030 (USD MILLION) 136
  • TABLE 110 MEXICO THROAT CANCER DIAGNOSTICS MARKET, BY END USER, 2021-2030 (USD MILLION) 137
  • TABLE 111 MEXICO THROAT CANCER DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION) 137

LIST OF FIGURES

  • FIGURE 1 NORTH AMERICA THROAT CANCER DIAGNOSTICS MARKET: SEGMENTATION 24
  • FIGURE 2 NORTH AMERICA THROAT CANCER DIAGNOSTICS MARKET: DATA TRIANGULATION 27
  • FIGURE 3 NORTH AMERICA THROAT CANCER DIAGNOSTICS MARKET: DROC ANALYSIS 28
  • FIGURE 4 NORTH AMERICA THROAT CANCER DIAGNOSTICS MARKET: NORTH AMERICA VS REGIONAL MARKET ANALYSIS 29
  • FIGURE 5 NORTH AMERICA THROAT CANCER DIAGNOSTICS MARKET: COMPANY RESEARCH ANALYSIS 29
  • FIGURE 6 NORTH AMERICA THROAT CANCER DIAGNOSTICS MARKET: INTERVIEW DEMOGRAPHICS 31
  • FIGURE 7 NORTH AMERICA THROAT CANCER DIAGNOSTICS MARKET: DBMR MARKET POSITION GRID 32
  • FIGURE 8 NORTH AMERICA THROAT CANCER DIAGNOSTICS MARKET: MARKET END USER COVERAGE GRID 33
  • FIGURE 9 NORTH AMERICA THROAT CANCER DIAGNOSTICS MARKET: VENDOR SHARE ANALYSIS 34
  • FIGURE 10 NORTH AMERICA THROAT CANCER DIAGNOSTICS MARKET: SEGMENTATION 38
  • FIGURE 11 THE INCREASE IN THE AWARENESS ABOUT THROAT CANCER IS EXPECTED TO DRIVE THE NORTH AMERICA THROAT CANCER DIAGNOSTICS MARKET GROWTH IN THE FORECAST PERIOD 39
  • FIGURE 12 THE INSTRUMENT TYPE SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE NORTH AMERICA THROAT CANCER DIAGNOSTICS MARKET IN 2023 & 2030 39
  • FIGURE 13 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE NORTH AMERICA THROAT CANCER DIAGNOSTICS MARKET 48
  • FIGURE 14 NORTH AMERICA THROAT CANCER DIAGNOSTICS MARKET: BY PRODUCT TYPE, 2022 55
  • FIGURE 15 NORTH AMERICA THROAT CANCER DIAGNOSTICS MARKET: BY PRODUCT TYPE, 2023-2030 (USD MILLION) 56
  • FIGURE 16 NORTH AMERICA THROAT CANCER DIAGNOSTICS MARKET: BY PRODUCT TYPE, CAGR (2023-2030) 56
  • FIGURE 17 NORTH AMERICA THROAT CANCER DIAGNOSTICS MARKET: BY PRODUCT TYPE, LIFELINE CURVE 57
  • FIGURE 18 NORTH AMERICA THROAT CANCER DIAGNOSTICS MARKET: BY TEST TYPE, 2022 65
  • FIGURE 19 NORTH AMERICA THROAT CANCER DIAGNOSTICS MARKET: BY TEST TYPE, 2023-2030 (USD MILLION) 66
  • FIGURE 20 NORTH AMERICA THROAT CANCER DIAGNOSTICS MARKET: BY TEST TYPE, CAGR (2023-2030) 66
  • FIGURE 21 NORTH AMERICA THROAT CANCER DIAGNOSTICS MARKET: BY TEST TYPE, LIFELINE CURVE 67
  • FIGURE 22 NORTH AMERICA THROAT CANCER DIAGNOSTICS MARKET: BY CANCER TYPE, 2022 75
  • FIGURE 23 NORTH AMERICA THROAT CANCER DIAGNOSTICS MARKET: BY CANCER TYPE, 2023-2030 (USD MILLION) 76
  • FIGURE 24 NORTH AMERICA THROAT CANCER DIAGNOSTICS MARKET: BY CANCER TYPE, CAGR (2023-2030) 76
  • FIGURE 25 NORTH AMERICA THROAT CANCER DIAGNOSTICS MARKET: BY CANCER TYPE, LIFELINE CURVE 77
  • FIGURE 26 NORTH AMERICA THROAT CANCER DIAGNOSTICS MARKET: BY STAGES, 2022 82
  • FIGURE 27 NORTH AMERICA THROAT CANCER DIAGNOSTICS MARKET: BY STAGES, 2023-2030 (USD MILLION) 83
  • FIGURE 28 NORTH AMERICA THROAT CANCER DIAGNOSTICS MARKET: BY STAGES, CAGR (2023-2030) 83
  • FIGURE 29 NORTH AMERICA THROAT CANCER DIAGNOSTICS MARKET: BY STAGES, LIFELINE CURVE 84
  • FIGURE 30 NORTH AMERICA THROAT CANCER DIAGNOSTICS MARKET: BY AGE GROUP, 2022 90
  • FIGURE 31 NORTH AMERICA THROAT CANCER DIAGNOSTICS MARKET: BY AGE GROUP, 2023-2030 (USD MILLION) 91
  • FIGURE 32 NORTH AMERICA THROAT CANCER DIAGNOSTICS MARKET: BY AGE GROUP, CAGR (2023-2030) 91
  • FIGURE 33 NORTH AMERICA THROAT CANCER DIAGNOSTICS MARKET: BY AGE GROUP, LIFELINE CURVE 92
  • FIGURE 34 NORTH AMERICA THROAT CANCER DIAGNOSTICS MARKET: BY END USER, 2022 97
  • FIGURE 35 NORTH AMERICA THROAT CANCER DIAGNOSTICS MARKET: BY END USER, 2023-2030 (USD MILLION) 98
  • FIGURE 36 NORTH AMERICA THROAT CANCER DIAGNOSTICS MARKET: BY END USER, CAGR (2023-2030) 98
  • FIGURE 37 NORTH AMERICA THROAT CANCER DIAGNOSTICS MARKET: BY END USER, LIFELINE CURVE 99
  • FIGURE 38 NORTH AMERICA THROAT CANCER DIAGNOSTICS MARKET: BY DISTRIBUTION CHANNEL, 2022 106
  • FIGURE 39 NORTH AMERICA THROAT CANCER DIAGNOSTICS MARKET: BY DISTRIBUTION CHANNEL, 2023-2030 (USD MILLION) 107
  • FIGURE 40 NORTH AMERICA THROAT CANCER DIAGNOSTICS MARKET: BY DISTRIBUTION CHANNEL, CAGR (2023-2030) 107
  • FIGURE 41 NORTH AMERICA THROAT CANCER DIAGNOSTICS MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE 108
  • FIGURE 42 NORTH AMERICA THROAT CANCER DIAGNOSTICS MARKET: SNAPSHOT (2022) 113
  • FIGURE 43 NORTH AMERICA THROAT CANCER DIAGNOSTICS MARKET: BY COUNTRY (2022) 115
  • FIGURE 44 NORTH AMERICA THROAT CANCER DIAGNOSTICS MARKET: BY COUNTRY (2023 & 2030) 115
  • FIGURE 45 NORTH AMERICA THROAT CANCER DIAGNOSTICS MARKET: BY COUNTRY (2023 & 2030) 116
  • FIGURE 46 NORTH AMERICA THROAT CANCER DIAGNOSTICS MARKET: PRODUCT TYPE (2023-2030) 116
  • FIGURE 47 NORTH AMERICA THROAT CANCER DIAGNOSTICS MARKET: COMPANY SHARE 2022 (%) 137
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!